Browse studies

Find your next paid study

1 recruiting study matching your filters

A Randomized Phase II, Double-blind, Multicenter Study Evaluating the Efficacy and Safety of Autogene Cevumeran Plus Nivolumab Versus Nivolumab as Adjuvant Therapy in Patients With High-risk Muscle-invasive Urothelial Carcinoma

The original purpose of this study was to evaluate the efficacy of adjuvant treatment with autogene cevumeran plus nivolumab compared with nivolumab in partici…

Muscle-invasive Urothelial Carcinoma

Estimated

~$10 – $7,500

Hoffmann-La RocheNCT06534983